nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0615	0.0943	CbGbCtD
Imipramine—CYP3A7—Dexamethasone—psoriatic arthritis	0.0477	0.073	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0477	0.073	CbGbCtD
Imipramine—CYP2C19—Prednisone—psoriatic arthritis	0.0462	0.0708	CbGbCtD
Imipramine—CYP2E1—Dexamethasone—psoriatic arthritis	0.046	0.0705	CbGbCtD
Imipramine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0454	0.0695	CbGbCtD
Imipramine—ABCB1—Betamethasone—psoriatic arthritis	0.04	0.0613	CbGbCtD
Imipramine—ABCB1—Prednisolone—psoriatic arthritis	0.0395	0.0605	CbGbCtD
Imipramine—ABCB1—Prednisone—psoriatic arthritis	0.0373	0.0571	CbGbCtD
Imipramine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0369	0.0565	CbGbCtD
Imipramine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0288	0.0442	CbGbCtD
Imipramine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0279	0.0428	CbGbCtD
Imipramine—CYP3A4—Betamethasone—psoriatic arthritis	0.024	0.0367	CbGbCtD
Imipramine—CYP3A4—Prednisolone—psoriatic arthritis	0.0236	0.0362	CbGbCtD
Imipramine—ABCB1—Dexamethasone—psoriatic arthritis	0.0233	0.0357	CbGbCtD
Imipramine—CYP3A4—Prednisone—psoriatic arthritis	0.0223	0.0342	CbGbCtD
Imipramine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0219	0.0336	CbGbCtD
Imipramine—ABCB1—Methotrexate—psoriatic arthritis	0.0187	0.0287	CbGbCtD
Imipramine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0139	0.0214	CbGbCtD
Imipramine—Benazepril—ACE—psoriatic arthritis	0.00139	1	CrCbGaD
Imipramine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000579	0.00167	CcSEcCtD
Imipramine—Oedema—Prednisolone—psoriatic arthritis	0.000579	0.00167	CcSEcCtD
Imipramine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000573	0.00166	CcSEcCtD
Imipramine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000572	0.00165	CcSEcCtD
Imipramine—Shock—Prednisolone—psoriatic arthritis	0.00057	0.00165	CcSEcCtD
Imipramine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000569	0.00165	CcSEcCtD
Imipramine—Convulsion—Triamcinolone—psoriatic arthritis	0.000565	0.00163	CcSEcCtD
Imipramine—Tachycardia—Prednisolone—psoriatic arthritis	0.000565	0.00163	CcSEcCtD
Imipramine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000564	0.00163	CcSEcCtD
Imipramine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000564	0.00163	CcSEcCtD
Imipramine—Hypertension—Triamcinolone—psoriatic arthritis	0.000563	0.00163	CcSEcCtD
Imipramine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000562	0.00162	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00056	0.00162	CcSEcCtD
Imipramine—Eye disorder—Prednisone—psoriatic arthritis	0.000553	0.0016	CcSEcCtD
Imipramine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000552	0.0016	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000551	0.00159	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—psoriatic arthritis	0.000551	0.00159	CcSEcCtD
Imipramine—Infestation—Methotrexate—psoriatic arthritis	0.000551	0.00159	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00055	0.00159	CcSEcCtD
Imipramine—Flushing—Prednisone—psoriatic arthritis	0.00055	0.00159	CcSEcCtD
Imipramine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000549	0.00159	CcSEcCtD
Imipramine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000549	0.00159	CcSEcCtD
Imipramine—Discomfort—Triamcinolone—psoriatic arthritis	0.000549	0.00159	CcSEcCtD
Imipramine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000548	0.00158	CcSEcCtD
Imipramine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000543	0.00157	CcSEcCtD
Imipramine—Stomatitis—Methotrexate—psoriatic arthritis	0.000537	0.00155	CcSEcCtD
Imipramine—Angiopathy—Prednisone—psoriatic arthritis	0.000537	0.00155	CcSEcCtD
Imipramine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000536	0.00155	CcSEcCtD
Imipramine—Immune system disorder—Prednisone—psoriatic arthritis	0.000535	0.00155	CcSEcCtD
Imipramine—Malaise—Dexamethasone—psoriatic arthritis	0.000534	0.00154	CcSEcCtD
Imipramine—Malaise—Betamethasone—psoriatic arthritis	0.000534	0.00154	CcSEcCtD
Imipramine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000532	0.00154	CcSEcCtD
Imipramine—Oedema—Triamcinolone—psoriatic arthritis	0.000532	0.00154	CcSEcCtD
Imipramine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000531	0.00154	CcSEcCtD
Imipramine—Syncope—Betamethasone—psoriatic arthritis	0.000531	0.00153	CcSEcCtD
Imipramine—Syncope—Dexamethasone—psoriatic arthritis	0.000531	0.00153	CcSEcCtD
Imipramine—Arrhythmia—Prednisone—psoriatic arthritis	0.000529	0.00153	CcSEcCtD
Imipramine—Infection—Triamcinolone—psoriatic arthritis	0.000529	0.00153	CcSEcCtD
Imipramine—Infection—Methylprednisolone—psoriatic arthritis	0.000528	0.00153	CcSEcCtD
Imipramine—Shock—Triamcinolone—psoriatic arthritis	0.000524	0.00151	CcSEcCtD
Imipramine—Insomnia—Prednisolone—psoriatic arthritis	0.000524	0.00151	CcSEcCtD
Imipramine—Alopecia—Prednisone—psoriatic arthritis	0.000523	0.00151	CcSEcCtD
Imipramine—Shock—Methylprednisolone—psoriatic arthritis	0.000523	0.00151	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000521	0.00151	CcSEcCtD
Imipramine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000521	0.00151	CcSEcCtD
Imipramine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00052	0.0015	CcSEcCtD
Imipramine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00052	0.0015	CcSEcCtD
Imipramine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00052	0.0015	CcSEcCtD
Imipramine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00052	0.0015	CcSEcCtD
Imipramine—Mental disorder—Prednisone—psoriatic arthritis	0.000519	0.0015	CcSEcCtD
Imipramine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000518	0.0015	CcSEcCtD
Imipramine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000516	0.00149	CcSEcCtD
Imipramine—Malnutrition—Prednisone—psoriatic arthritis	0.000515	0.00149	CcSEcCtD
Imipramine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000515	0.00149	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000514	0.00149	CcSEcCtD
Imipramine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000514	0.00148	CcSEcCtD
Imipramine—Convulsion—Betamethasone—psoriatic arthritis	0.000513	0.00148	CcSEcCtD
Imipramine—Convulsion—Dexamethasone—psoriatic arthritis	0.000513	0.00148	CcSEcCtD
Imipramine—Hypertension—Dexamethasone—psoriatic arthritis	0.000511	0.00148	CcSEcCtD
Imipramine—Hypertension—Betamethasone—psoriatic arthritis	0.000511	0.00148	CcSEcCtD
Imipramine—Anxiety—Betamethasone—psoriatic arthritis	0.000502	0.00145	CcSEcCtD
Imipramine—Anxiety—Dexamethasone—psoriatic arthritis	0.000502	0.00145	CcSEcCtD
Imipramine—Discomfort—Betamethasone—psoriatic arthritis	0.000498	0.00144	CcSEcCtD
Imipramine—Discomfort—Dexamethasone—psoriatic arthritis	0.000498	0.00144	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—psoriatic arthritis	0.000495	0.00143	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000489	0.00141	CcSEcCtD
Imipramine—Vision blurred—Prednisone—psoriatic arthritis	0.000486	0.0014	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000485	0.0014	CcSEcCtD
Imipramine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000483	0.0014	CcSEcCtD
Imipramine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000483	0.0014	CcSEcCtD
Imipramine—Oedema—Betamethasone—psoriatic arthritis	0.000483	0.0014	CcSEcCtD
Imipramine—Oedema—Dexamethasone—psoriatic arthritis	0.000483	0.0014	CcSEcCtD
Imipramine—Insomnia—Triamcinolone—psoriatic arthritis	0.000482	0.00139	CcSEcCtD
Imipramine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00048	0.00139	CcSEcCtD
Imipramine—Infection—Betamethasone—psoriatic arthritis	0.00048	0.00139	CcSEcCtD
Imipramine—Infection—Dexamethasone—psoriatic arthritis	0.00048	0.00139	CcSEcCtD
Imipramine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000478	0.00138	CcSEcCtD
Imipramine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000478	0.00138	CcSEcCtD
Imipramine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000477	0.00138	CcSEcCtD
Imipramine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000477	0.00138	CcSEcCtD
Imipramine—Shock—Betamethasone—psoriatic arthritis	0.000475	0.00137	CcSEcCtD
Imipramine—Shock—Dexamethasone—psoriatic arthritis	0.000475	0.00137	CcSEcCtD
Imipramine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000474	0.00137	CcSEcCtD
Imipramine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000474	0.00137	CcSEcCtD
Imipramine—Agitation—Prednisone—psoriatic arthritis	0.000474	0.00137	CcSEcCtD
Imipramine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000473	0.00137	CcSEcCtD
Imipramine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000473	0.00137	CcSEcCtD
Imipramine—Tachycardia—Betamethasone—psoriatic arthritis	0.000471	0.00136	CcSEcCtD
Imipramine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000471	0.00136	CcSEcCtD
Imipramine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000469	0.00135	CcSEcCtD
Imipramine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000468	0.00135	CcSEcCtD
Imipramine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000467	0.00135	CcSEcCtD
Imipramine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000467	0.00135	CcSEcCtD
Imipramine—Malaise—Prednisone—psoriatic arthritis	0.000465	0.00134	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—psoriatic arthritis	0.000462	0.00134	CcSEcCtD
Imipramine—Syncope—Prednisone—psoriatic arthritis	0.000462	0.00134	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—psoriatic arthritis	0.000461	0.00133	CcSEcCtD
Imipramine—Anorexia—Betamethasone—psoriatic arthritis	0.00046	0.00133	CcSEcCtD
Imipramine—Anorexia—Dexamethasone—psoriatic arthritis	0.00046	0.00133	CcSEcCtD
Imipramine—Urticaria—Prednisolone—psoriatic arthritis	0.00046	0.00133	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000459	0.00133	CcSEcCtD
Imipramine—Fatigue—Triamcinolone—psoriatic arthritis	0.000459	0.00133	CcSEcCtD
Imipramine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000458	0.00132	CcSEcCtD
Imipramine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000453	0.00131	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—psoriatic arthritis	0.000449	0.0013	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000447	0.00129	CcSEcCtD
Imipramine—Convulsion—Prednisone—psoriatic arthritis	0.000447	0.00129	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000446	0.00129	CcSEcCtD
Imipramine—Hypertension—Prednisone—psoriatic arthritis	0.000445	0.00129	CcSEcCtD
Imipramine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000439	0.00127	CcSEcCtD
Imipramine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000438	0.00126	CcSEcCtD
Imipramine—Anxiety—Prednisone—psoriatic arthritis	0.000437	0.00126	CcSEcCtD
Imipramine—Alopecia—Methotrexate—psoriatic arthritis	0.000437	0.00126	CcSEcCtD
Imipramine—Insomnia—Betamethasone—psoriatic arthritis	0.000437	0.00126	CcSEcCtD
Imipramine—Insomnia—Dexamethasone—psoriatic arthritis	0.000437	0.00126	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000436	0.00126	CcSEcCtD
Imipramine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000434	0.00126	CcSEcCtD
Imipramine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000434	0.00125	CcSEcCtD
Imipramine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000434	0.00125	CcSEcCtD
Imipramine—Discomfort—Prednisone—psoriatic arthritis	0.000434	0.00125	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—psoriatic arthritis	0.000434	0.00125	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—psoriatic arthritis	0.000431	0.00124	CcSEcCtD
Imipramine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000425	0.00123	CcSEcCtD
Imipramine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000425	0.00123	CcSEcCtD
Imipramine—Urticaria—Triamcinolone—psoriatic arthritis	0.000423	0.00122	CcSEcCtD
Imipramine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000422	0.00122	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000422	0.00122	CcSEcCtD
Imipramine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000421	0.00122	CcSEcCtD
Imipramine—Oedema—Prednisone—psoriatic arthritis	0.000421	0.00122	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000421	0.00122	CcSEcCtD
Imipramine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00042	0.00121	CcSEcCtD
Imipramine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00042	0.00121	CcSEcCtD
Imipramine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00042	0.00121	CcSEcCtD
Imipramine—Infection—Prednisone—psoriatic arthritis	0.000418	0.00121	CcSEcCtD
Imipramine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000417	0.00121	CcSEcCtD
Imipramine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000417	0.00121	CcSEcCtD
Imipramine—Fatigue—Betamethasone—psoriatic arthritis	0.000417	0.0012	CcSEcCtD
Imipramine—Fatigue—Dexamethasone—psoriatic arthritis	0.000417	0.0012	CcSEcCtD
Imipramine—Shock—Prednisone—psoriatic arthritis	0.000414	0.0012	CcSEcCtD
Imipramine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000413	0.00119	CcSEcCtD
Imipramine—Tachycardia—Prednisone—psoriatic arthritis	0.000411	0.00119	CcSEcCtD
Imipramine—Skin disorder—Prednisone—psoriatic arthritis	0.000409	0.00118	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000407	0.00118	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—psoriatic arthritis	0.000406	0.00117	CcSEcCtD
Imipramine—Anorexia—Prednisone—psoriatic arthritis	0.000401	0.00116	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.0004	0.00116	CcSEcCtD
Imipramine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000398	0.00115	CcSEcCtD
Imipramine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000398	0.00115	CcSEcCtD
Imipramine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000395	0.00114	CcSEcCtD
Imipramine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000395	0.00114	CcSEcCtD
Imipramine—Malaise—Methotrexate—psoriatic arthritis	0.000389	0.00112	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—psoriatic arthritis	0.000386	0.00111	CcSEcCtD
Imipramine—Urticaria—Betamethasone—psoriatic arthritis	0.000384	0.00111	CcSEcCtD
Imipramine—Urticaria—Dexamethasone—psoriatic arthritis	0.000384	0.00111	CcSEcCtD
Imipramine—Dizziness—Prednisolone—psoriatic arthritis	0.000383	0.00111	CcSEcCtD
Imipramine—Asthenia—Triamcinolone—psoriatic arthritis	0.000382	0.0011	CcSEcCtD
Imipramine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000382	0.0011	CcSEcCtD
Imipramine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000382	0.0011	CcSEcCtD
Imipramine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000382	0.0011	CcSEcCtD
Imipramine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000382	0.0011	CcSEcCtD
Imipramine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000381	0.0011	CcSEcCtD
Imipramine—Insomnia—Prednisone—psoriatic arthritis	0.000381	0.0011	CcSEcCtD
Imipramine—Paraesthesia—Prednisone—psoriatic arthritis	0.000378	0.00109	CcSEcCtD
Imipramine—Pruritus—Triamcinolone—psoriatic arthritis	0.000377	0.00109	CcSEcCtD
Imipramine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000376	0.00109	CcSEcCtD
Imipramine—Convulsion—Methotrexate—psoriatic arthritis	0.000373	0.00108	CcSEcCtD
Imipramine—Dyspepsia—Prednisone—psoriatic arthritis	0.00037	0.00107	CcSEcCtD
Imipramine—Decreased appetite—Prednisone—psoriatic arthritis	0.000366	0.00106	CcSEcCtD
Imipramine—Rash—Prednisolone—psoriatic arthritis	0.000365	0.00105	CcSEcCtD
Imipramine—Dermatitis—Prednisolone—psoriatic arthritis	0.000365	0.00105	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000364	0.00105	CcSEcCtD
Imipramine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000363	0.00105	CcSEcCtD
Imipramine—Fatigue—Prednisone—psoriatic arthritis	0.000363	0.00105	CcSEcCtD
Imipramine—Headache—Prednisolone—psoriatic arthritis	0.000363	0.00105	CcSEcCtD
Imipramine—Discomfort—Methotrexate—psoriatic arthritis	0.000362	0.00105	CcSEcCtD
Imipramine—Constipation—Prednisone—psoriatic arthritis	0.00036	0.00104	CcSEcCtD
Imipramine—Confusional state—Methotrexate—psoriatic arthritis	0.000355	0.00102	CcSEcCtD
Imipramine—Dizziness—Triamcinolone—psoriatic arthritis	0.000352	0.00102	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000352	0.00102	CcSEcCtD
Imipramine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000351	0.00102	CcSEcCtD
Imipramine—Infection—Methotrexate—psoriatic arthritis	0.000349	0.00101	CcSEcCtD
Imipramine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000347	0.001	CcSEcCtD
Imipramine—Asthenia—Dexamethasone—psoriatic arthritis	0.000347	0.001	CcSEcCtD
Imipramine—Asthenia—Betamethasone—psoriatic arthritis	0.000347	0.001	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000345	0.000996	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000344	0.000995	CcSEcCtD
Imipramine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000344	0.000994	CcSEcCtD
Imipramine—Nausea—Prednisolone—psoriatic arthritis	0.000344	0.000994	CcSEcCtD
Imipramine—Pruritus—Betamethasone—psoriatic arthritis	0.000342	0.000988	CcSEcCtD
Imipramine—Pruritus—Dexamethasone—psoriatic arthritis	0.000342	0.000988	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—psoriatic arthritis	0.000342	0.000987	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00034	0.000982	CcSEcCtD
Imipramine—Vomiting—Triamcinolone—psoriatic arthritis	0.000339	0.000978	CcSEcCtD
Imipramine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000338	0.000976	CcSEcCtD
Imipramine—Rash—Triamcinolone—psoriatic arthritis	0.000336	0.00097	CcSEcCtD
Imipramine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000335	0.000969	CcSEcCtD
Imipramine—Anorexia—Methotrexate—psoriatic arthritis	0.000335	0.000968	CcSEcCtD
Imipramine—Rash—Methylprednisolone—psoriatic arthritis	0.000335	0.000968	CcSEcCtD
Imipramine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000335	0.000967	CcSEcCtD
Imipramine—Urticaria—Prednisone—psoriatic arthritis	0.000334	0.000966	CcSEcCtD
Imipramine—Headache—Triamcinolone—psoriatic arthritis	0.000334	0.000964	CcSEcCtD
Imipramine—Headache—Methylprednisolone—psoriatic arthritis	0.000333	0.000962	CcSEcCtD
Imipramine—Body temperature increased—Prednisone—psoriatic arthritis	0.000333	0.000961	CcSEcCtD
Imipramine—Abdominal pain—Prednisone—psoriatic arthritis	0.000333	0.000961	CcSEcCtD
Imipramine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000331	0.000955	CcSEcCtD
Imipramine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000331	0.000955	CcSEcCtD
Imipramine—Dizziness—Dexamethasone—psoriatic arthritis	0.000319	0.000923	CcSEcCtD
Imipramine—Dizziness—Betamethasone—psoriatic arthritis	0.000319	0.000923	CcSEcCtD
Imipramine—Insomnia—Methotrexate—psoriatic arthritis	0.000318	0.000919	CcSEcCtD
Imipramine—Nausea—Triamcinolone—psoriatic arthritis	0.000316	0.000914	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000316	0.000912	CcSEcCtD
Imipramine—Nausea—Methylprednisolone—psoriatic arthritis	0.000316	0.000912	CcSEcCtD
Imipramine—Somnolence—Methotrexate—psoriatic arthritis	0.000313	0.000903	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00031	0.000894	CcSEcCtD
Imipramine—Vomiting—Dexamethasone—psoriatic arthritis	0.000307	0.000888	CcSEcCtD
Imipramine—Vomiting—Betamethasone—psoriatic arthritis	0.000307	0.000888	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000306	0.000883	CcSEcCtD
Imipramine—Rash—Dexamethasone—psoriatic arthritis	0.000305	0.00088	CcSEcCtD
Imipramine—Rash—Betamethasone—psoriatic arthritis	0.000305	0.00088	CcSEcCtD
Imipramine—Dermatitis—Betamethasone—psoriatic arthritis	0.000304	0.000879	CcSEcCtD
Imipramine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000304	0.000879	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000304	0.000877	CcSEcCtD
Imipramine—Fatigue—Methotrexate—psoriatic arthritis	0.000303	0.000876	CcSEcCtD
Imipramine—Headache—Dexamethasone—psoriatic arthritis	0.000303	0.000875	CcSEcCtD
Imipramine—Headache—Betamethasone—psoriatic arthritis	0.000303	0.000875	CcSEcCtD
Imipramine—Asthenia—Prednisone—psoriatic arthritis	0.000302	0.000872	CcSEcCtD
Imipramine—Pruritus—Prednisone—psoriatic arthritis	0.000298	0.00086	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00029	0.000837	CcSEcCtD
Imipramine—Diarrhoea—Prednisone—psoriatic arthritis	0.000288	0.000832	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000288	0.000831	CcSEcCtD
Imipramine—Nausea—Dexamethasone—psoriatic arthritis	0.000287	0.000829	CcSEcCtD
Imipramine—Nausea—Betamethasone—psoriatic arthritis	0.000287	0.000829	CcSEcCtD
Imipramine—Urticaria—Methotrexate—psoriatic arthritis	0.000279	0.000807	CcSEcCtD
Imipramine—Dizziness—Prednisone—psoriatic arthritis	0.000278	0.000804	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000278	0.000803	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000278	0.000803	CcSEcCtD
Imipramine—Vomiting—Prednisone—psoriatic arthritis	0.000267	0.000773	CcSEcCtD
Imipramine—Rash—Prednisone—psoriatic arthritis	0.000265	0.000767	CcSEcCtD
Imipramine—Dermatitis—Prednisone—psoriatic arthritis	0.000265	0.000766	CcSEcCtD
Imipramine—Headache—Prednisone—psoriatic arthritis	0.000264	0.000762	CcSEcCtD
Imipramine—Asthenia—Methotrexate—psoriatic arthritis	0.000252	0.000729	CcSEcCtD
Imipramine—Nausea—Prednisone—psoriatic arthritis	0.00025	0.000722	CcSEcCtD
Imipramine—Pruritus—Methotrexate—psoriatic arthritis	0.000249	0.000719	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000241	0.000695	CcSEcCtD
Imipramine—Dizziness—Methotrexate—psoriatic arthritis	0.000233	0.000672	CcSEcCtD
Imipramine—Vomiting—Methotrexate—psoriatic arthritis	0.000224	0.000646	CcSEcCtD
Imipramine—Rash—Methotrexate—psoriatic arthritis	0.000222	0.000641	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—psoriatic arthritis	0.000221	0.00064	CcSEcCtD
Imipramine—Headache—Methotrexate—psoriatic arthritis	0.00022	0.000636	CcSEcCtD
Imipramine—Nausea—Methotrexate—psoriatic arthritis	0.000209	0.000603	CcSEcCtD
